Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C
V. Loustaud‐Ratti(Hôpital Dupuytren), Elisabeth Vidal(Centre Hospitalier Universitaire de Limoges), Annick Rousseau(Inserm), Annie Lefebvre(Centre Hospitalier Universitaire de Limoges), Sophie Alain(Université de Limoges), A.L. Fauchais(Hôpital Dupuytren), Eric Liozon(Centre Hospitalier Universitaire de Limoges), François Denis(Inserm), F. Lunel(Centre Hospitalier Universitaire d'Angers), François Ludovic Sauvage(Inserm), Pierre Marquet(Inserm), I. Hubert(Centre Hospitalier Universitaire d'Angers), Paul Calès(Centre Hospitalier Universitaire d'Angers)
Cited by 85
Related Papers
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
|The Lancet Infectious Diseases|2017|822
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299
Bacterial Populations Contaminating The Upper Gut in Patients With Small Intestinal Bacterial Overgrowth Syndrome
|The American Journal of Gastroenterology|1999|196
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2021|185
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
|Journal of Antimicrobial Chemotherapy|2010|163